127.79
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $127.79, with a volume of 310.30K.
It is up +1.01% in the last 24 hours and down -3.74% over the past month.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
See More
Previous Close:
$126.51
Open:
$127.15
24h Volume:
310.30K
Relative Volume:
0.41
Market Cap:
$5.66B
Revenue:
$2.81B
Net Income/Loss:
$-294.68M
P/E Ratio:
-5.6024
EPS:
-22.8098
Net Cash Flow:
$232.59M
1W Performance:
+0.62%
1M Performance:
-3.74%
6M Performance:
+4.46%
1Y Performance:
+7.25%
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TFX
Teleflex Incorporated
|
127.79 | 5.60B | 2.81B | -294.68M | 232.59M | -22.81 |
|
ISRG
Intuitive Surgical Inc
|
399.69 | 142.31B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
151.38 | 40.72B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
68.13 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
37.77 | 30.48B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
198.60 | 28.50B | 5.54B | 1.52B | 1.74B | 10.37 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Upgrade | BofA Securities | Underperform → Neutral |
| Mar-27-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-27-26 | Upgrade | Needham | Hold → Buy |
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Price to earnings forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex Incorporated Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh - TradingView
Teleflex Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Enterprise value to revenue forward of Teleflex Incorporated – NYSE:TFX - TradingView
TFX Forecast — Price Target — Prediction for 2027 - TradingView
Teleflex launches BIOMAG III trial, analyst consensus on the shares stays cautious - Ad-hoc-news.de
Enterprise value to revenue forward of Teleflex Incorporated – BX:TBH - TradingView
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Do Options Traders Know Something About Teleflex Stock We Don't? - TradingView
The Freesolve Resorbable Magnesium Scaffold from Teleflex Inc.global BIOMAG-III trial puts the co - Ad-hoc-news.de
Teleflex Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Teleflex begins enrollment in BIOMAG-III pivotal study - grafa.com
Teleflex Starts Enrollment in Resorbable Magnesium Scaffold Study - Medical Product Outsourcing
Teleflex begins enrollment in pivotal resorbable scaffold study By Investing.com - Investing.com Australia
Teleflex begins enrollment in pivotal resorbable scaffold study - Investing.com
Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold - Business Wire
Teleflex reports muted share move, analyst metrics frame the stock - AD HOC NEWS
Teleflex Inc (TFX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Teleflex Inc (TFX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Teleflex Inc (TFX) Shares Fall 4.2% -- What GF Score of 76 Tells Investors - GuruFocus
Teleflex Inc. stock underperforms Monday when compared to competitors - MarketWatch
Teleflex adjusts debt profile with new senior notes, shares in focus on NYSE - AD HOC NEWS
Teleflex Inc (TFX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Irenic Capital Management LP's Teleflex Inc(TFX) Holding History - GuruFocus
Teleflex StockLong-term strategy and medical device focus - AD HOC NEWS
How Investors Are Reacting To Teleflex (TFX) $500 Million 5.875% Senior Notes To Fund Transformation - Sahm
Teleflex Inc (TFX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Teleflex Inc (TFX) Institutional Confidence - TradingKey
Why Teleflex's Weck EFx Shield Fascial Closure System aims to make ports safer - AD HOC NEWS
Teleflex Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Surgical Equipment & ConsumablesSpecialty Stocks Q1 Recap: Benchmarking Teleflex (NYSE:TFX) - Yahoo Finance
Mangrove Partners IM LLC Buys Shares of 256,726 Teleflex Incorporated $TFX - MarketBeat
Teleflex Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Teleflex Inc. 2026 Indenture: Key Covenants, Redemption Terms, and SEC Compliance for Senior Notes - Minichart
Teleflex issues $500 million in 5.875% senior notes due 2032 By Investing.com - Investing.com Canada
Teleflex Issues New Senior Notes to Strengthen Capital Structure - TipRanks
Teleflex issues $500 million in 5.875% senior notes due 2032 - Investing.com
Teleflex Issues $500 Million 5.875% Senior Notes Due 2032 Under New Indenture - TradingView
Teleflex Incorporated Issues $500,000,000 Senior Notes Due January 2032 - marketscreener.com
Teleflex (NYSE: TFX) sells $500M 5.875% senior notes due 2032 - Stock Titan
Teleflex’s Global Expansion Boosts Stock Performance - timothysykes.com
Activist Pressure Fuels Teleflex Stock Uplift Amid Bold Corporate Moves - timothysykes.com
Teleflex Inc. Stock (US8793691069): Moody’s Ba2 rating and valuation in focus - AD HOC NEWS
How Teleflex Incorporated (TFX) Affects Rotational Strategy Timing - Stock Traders Daily
Teleflex Inc. Stock (US8793691069): Valuation metrics in focus for US investors - AD HOC NEWS
Teleflex Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Will Teleflex's (TFX) Note Refinancing and Freesolve Data Shift Its Acquisition-Led Innovation Narrative? - simplywall.st
Teleflex grants special RSU award to interim CEO - The Globe and Mail
Assessing Teleflex (TFX) Valuation After Positive Four Year BIOMAG I Follow Up Data - Sahm
Teleflex Inc (TFX) Stock Up 3.0% and Still Undervalued -- GF Sco - GuruFocus
Teleflex (NYSE: TFX) director receives new RSU and option grants - Stock Titan
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):